Aparna Anand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aparna Anand has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Abhinay Sharma
Department of Microbiology and Molecular Genetics, The Institute for Medical Research, Israel-Canada (IMRIC), Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, 9112102, Israel
1 shared publication Atul Kumar Johri
School of Life Sciences, Jawaharlal Nehru University, New Mehrauli Road, New Delhi 110067, India
1 shared publication- Boaz Tirosh
Department of Biochemistry Case Western Reserve University School of Medicine Cleveland Ohio USA
1 shared publication Debabrata Biswas
Singapore-HUJ Alliance for Research and Enterprise, MMID Phase II, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore 117576, Singapore
1 shared publication- Emanuel Hanski
Department of Microbiology and Molecular Genetics, The Institute for Medical Research, Israel-Canada (IMRIC), Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel
1 shared publication Kimberly Xuan Zhen Lim
Singapore-HUJ Alliance for Research and Enterprise, MMID Phase II, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore 117576, Singapore
1 shared publication
Latest Publications
- 4 August 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (605)
Unfolded protein response inhibitors cure group A streptococcal necrotizing fasciitis by modulating host asparagine
Inhibiting the formation and release of host asparagine cures invasive group A streptococcal infections in mice.
- 4 August 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (605)
Unfolded protein response inhibitors cure group A streptococcal necrotizing fasciitis by modulating host asparagine
Inhibiting the formation and release of host asparagine cures invasive group A streptococcal infections in mice.